Link 1

Business & Investment

These are the newest stories for this topic.
See all

Medifirst Solutions Announces Negotiations To Bring Time Machine Laser To The China Market

Medifirst Solutions Banner

FREEHOLD, New Jersey — Medifirst Solutions a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device, announced that it was in negotiations to bring its FDA cleared Time Machine Laser to the China Market. With the recent addition of Life Science Quest, a medical device business development consulting firm, and the efforts and expertise of its founder Ruobing Xia, Medifirst will be meeting with a very prominent China-based medical organization to complete negotiations for a business venture that will involve exclusive rights to sell the Time Machine Laser for the entire country of China.

Read the full article...

Dental Membrane and Bone Graft Substitutes Market Is Exhibiting A Strong CAGR Of 9.3% By 2024

Dental Membrane and Bone Graft Substitutes 2016 Revenues

ALBANY, New York — According to a recent report by Transparency Market Research, dental membrane and bone graft substitutes market is anticipated to witness a sound growth with a steady CAGR of 9.3% within the forecast period from 2016 to 2024. The market is expected to soar around the value uS$922.6 mn in 2024, from US$419 mn in 2015. Based on product type, the market for dental membrane and bone graft substitutes is led by bone graft substitute segment, in which allograft procedure accounts for a strong position in the market due to its comfortable acceptance by the human body, coupled with its biocompatibility property. In dental membrane market, the restorable membrane is anticipated to be the dominant segment.

Read the full article...

Patterson Companies Denies Allegations Contained In FTC Administrative Complaint

ST PAUL, Minnesota — Patterson Companies, Inc. (Nasdaq: PDCO) today announced that the Federal Trade Commission (FTC) has issued an administrative complaint against Patterson alleging an agreement with its competitors not to sell to “buying groups” in violation of federal antitrust laws.

Read the full article...

Have You Met The Latest "Disrupter To Dentistry?"

NEW YORK, New York — Floss Bar, the New York City brainchild of a former hedge fund manager, opened for business last fall and promised a new era in dental health that brings lower prices, hyper-flexible scheduling and high-quality, preventive dental care.

Read the full article...

Align Technology Advanced Treatment Planning Patent Affirmed By Three-Judge Panel

SAN JOSE, California — Align Technology, Inc. (NASDAQ: ALGN) announced today that on February 5, 2018, a three-judge panel of the Patent Trial and Appeal Board ("PTAB") entered its decision refusing to institute an inter partes review ("IPR") trial proceeding sought by ClearCorrect to challenge the patentability of Align's patent no. 8,038,444, entitled "Automated Treatment Staging for Teeth" ("the '444 patent"). The decision found that ClearCorrect had failed to show a reasonable likelihood that any of the 42 claims in the '444 patent were unpatentable, and thus the panel unanimously refused to institute the trial proceeding requested by ClearCorrect.

Read the full article...

Global Tooth Replacement Market Report 2017-2022

Dr James Nickman$13 Billion Opportunity Analysis and Industry Forecasts

DUBLIN, Ireland — The Tooth Replacement Market - Global Opportunity Analysis and Industry Forecasts to 2022 report his now available at The global tooth replacement market will grow at a CAGR of 6.9% during the forecast period to reach USD 13,035.2 million by 2022

Read the full article...

Donald M. Casey Jr. Appointed Chief Executive Officer Of Dentsply Sirona

Donald Casey JrYORK, Pennsylvania — Dentsply Sirona Inc. ("Dentsply Sirona") (NASDAQ:XRAY), The Dental Solutions Company™, today announced that its Board of Directors has appointed Donald M. Casey Jr. as Chief Executive Officer and as a member of the Company's Board of Directors, effective February 12, 2018. Mr. Casey succeeds Mark A. Thierer, who served as Interim Chief Executive Officer since September 28, 2017. Mr. Thierer will continue to serve as Interim Chief Executive Officer through February 11, 2018 and will work closely with Mr. Casey to ensure a seamless transition.

Read the full article...

Dentsply Sirona Announces The Addition Of New Board Members

YORK, Pennsylvania — Dentsply Sirona Inc. ("Dentsply Sirona") (NASDAQ:XRAY), The Dental Solutions Company™, today announced that the size of its Board of Directors has been increased from nine to twelve members and that three new board members have been appointed. Joining the Board of Directors are Betsy D. Holden and Leslie F. Varon, in addition to Don M. Casey Jr., Dentsply Sirona's newly appointed Chief Executive Officer.

Read the full article...

3M Files Patent Infringement Lawsuit To Protect Dental Restorative Technology

ST PAUL, Minnesota — 3M Co. and 3M Innovative Properties Co. filed a patent infringement lawsuit in federal district court in Wilmington, Delaware last week against Kerr Corporation. The suit alleges that Kerr Corporation's SonicFill™ 2 and Harmonize™ dental composite materials infringe 3M's patent rights directed to nanotechnology used in 3M™ Filtek™ Supreme universal dental restoratives.

Read the full article...

ADA Health Policy Institute Report Shows Dental Spending Increased Again In 2016

CHICAGO, Illinois — For the second year in a row, dental spending increased after being flat for several years, according to a new report from the American Dental Association (ADA) Health Policy Institute. National dental expenditures were $124 billion in 2016, up from $120 billion in 2015 — a 3.3 percent increase, according to the analysis, U.S. Dental Expenditures 2017 Update.

Read the full article...

Page 1 | 2 | 3 ... 87 | 88 >>
This site is intended for your general information only. Is not a substitute for medical advice or treatment.
Use of this site is subject to our Terms of Use.
Page created in 0.668320894241 seconds.